Your questions about scalp & skin health —
hair loss, acne, dry skin, and beyond —
answered honestly.

Diffuse thinning is the most common — and most overlooked — form of hair loss. Unlike traction alopecia or CCCA, which show up in specific areas, diffuse thinning happens evenly across the entire scalp. Your part doesn't dramatically widen. Your hairline doesn't visibly recede. Instead, everything just gets thinner, flatter, and less dense — gradually, over years.

That's exactly why it's so hard to catch early. Most women attribute it to stress, aging, or genetics and don't seek treatment until significant density is already lost. The truth is diffuse thinning almost always has an addressable root cause — hormonal shifts, nutritional deficiency, chronic scalp inflammation, or a disrupted follicle cycle — and the earlier it's treated, the better the outcome.

The four conditions we see most frequently:

• Diffuse thinning — overall density loss across the scalp, often hormonal or nutritional in origin. The most common and most underdiagnosed.
• Traction Alopecia — recession of the hairline and edges caused by years of mechanical tension from tight braids, weaves, or extensions. Follicles aren't dead — they're dormant and can often be reactivated.
• CCCA (Central Centrifugal Cicatricial Alopecia) — begins at the crown as what looks like a widening part, accompanied by scalp tenderness, burning, or itching. If untreated, it causes permanent scarring of the follicle. Early intervention is critical.
• Androgenetic Alopecia — hormonally driven thinning that follows a pattern, most visibly along the top and crown. More common after menopause.

It depends on how long it has been present and whether the follicle itself has been permanently scarred. In most cases of diffuse thinning, traction alopecia, and early-to-mid stage CCCA, the follicles are not dead — they are dormant, congested, or inflamed. With the right clinical intervention, they can be reactivated.

Late-stage CCCA, where fibrotic scarring has replaced the follicle tissue entirely, is the exception. This is why early treatment matters enormously — the difference between reversible and permanent loss is often a matter of months.

Yes — both are significant contributors and are addressed directly in the Kapyderm home treatment system. Chronic stress elevates cortisol, which disrupts the hair growth cycle and pushes follicles prematurely into the shedding phase. Nutritional deficiency — particularly iron, zinc, biotin, and certain amino acids — starves the hair bulb of what it needs to produce strong terminal hair.

This is why the Kapyderm system includes internal supplementation alongside topical treatment. Treating the scalp surface without addressing internal deficiency produces incomplete results.

Standard trichology focuses primarily on the hair fiber — its structure, porosity, and external condition. Dermotricology treats the scalp as living skin — a complex biological ecosystem that directly determines the quality, density, and longevity of the hair it produces.

Where a standard trichologist might recommend a protein treatment or a scalp oil, a Dermotricologist performs a clinical analysis of the follicle environment — sebum balance, microcirculation, inflammatory markers, and cellular health — and prescribes a precise protocol to restore that environment at a biological level.

The results are categorically different because the approach is categorically different. Laboratorios Kapyderm has been developing and refining these plant-based clinical protocols for over 35 years.

GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound cause hair loss through two simultaneous mechanisms. The first is telogen effluvium — the rapid physiological change triggered by significant weight loss pushes a large percentage of follicles prematurely into the shedding phase. The second is nutritional deficiency: GLP-1 medications dramatically reduce appetite and caloric intake, often creating deficits in protein, iron, zinc, and biotin — the exact nutrients hair follicles require to sustain healthy growth.

The hair loss typically begins 2–4 months after starting the medication — which is why many patients don't immediately connect the two. The good news: GLP-1 hair loss is almost always reversible when the nutritional environment is corrected and the follicle cycle is clinically supported.

No — but clinical data suggests a significant percentage of GLP-1 users experience some degree of hair shedding. Studies on semaglutide report hair loss in 3–7% of participants in clinical trials, but real-world reports suggest the incidence is considerably higher — particularly among patients losing weight rapidly or eating insufficient protein. Women over 35 are disproportionately affected due to existing hormonal sensitivity of the follicle.

The risk is highest in the first 3–6 months of GLP-1 therapy and typically self-corrects if nutritional status is maintained. Without clinical support, however, some patients experience prolonged or worsening shedding that requires intervention.

In most cases, yes — but the timeline depends on how long the nutritional deficit was sustained and whether there was any pre-existing follicle vulnerability (hormonal hair loss, CCCA, or androgenetic alopecia) that the GLP-1 shedding is now expressing. Telogen effluvium from GLP-1 medications is almost always temporary when addressed correctly.

The Kapyderm Dermotricology protocol for GLP-1 hair loss focuses on three simultaneous interventions: restoring the internal nutritional environment (dePure + Revital internal supplementation), clearing scalp congestion that accumulated during the shedding phase (Organic Turba + Normalizing Cleanser), and stimulating follicle reactivation (Ampoule N + K2 Oil topical protocol). Both home treatment and in-center professional protocols are available.

Yes — the mechanism is identical and often more severe. Post-bariatric hair loss combines telogen effluvium from rapid weight loss with significant malabsorption of the nutrients hair follicles need. Protein deficiency after bariatric surgery is particularly severe, since the stomach's reduced capacity limits protein intake exactly when the body needs it most. Hair loss typically peaks at months 3–6 post-surgery and can be prolonged without clinical nutritional and scalp support.

A Dermotricologist (also spelled Dermotrichologist) is a certified professional trained in the Kapyderm Dermotricology clinical system — a licensed cosmetologist, trichologist, or esthetician who has completed the full Kapyderm certification program through Fundesmo USA, the exclusive U.S. source of Dermotricology education. Dermotricology and Dermotrichology refer to the same specialty — Dermotricology is the original Spanish spelling from Laboratorios Kapyderm; Dermotrichology is the alternate English spelling. Both describe the same clinical practice.

A Dermotricologist is distinct from a trichologist (who specializes in hair fiber science) and a dermatologist (a licensed medical doctor). Dermotricologists are not medical doctors — they are clinical professionals certified in the Kapyderm plant-based protocol system for scalp and skin health. In the U.S., every certified Technician of Dermotricology was trained and certified by Marlen Arita, Master in Dermotricology and Clinical Director of Kapyderm USA.

PIILIF (Perifollicular Inflammatory Infiltrate with Lipid-rich Foam cells) is a 2026 research advancement in understanding chronic follicular inflammation — the precise cellular mechanism behind androgenetic alopecia and other progressive hair loss conditions. Research published in 2026 identified PIILIF as the inflammatory process that causes progressive follicular miniaturization — the shrinking of follicles over time that turns terminal hair into fine vellus hair.

This is clinically significant because it explains why anti-inflammatory scalp treatment is effective for androgenetic alopecia — a condition previously thought to be purely hormonal (DHT-driven). The Kapyderm Dermotricology protocol's anti-inflammatory botanical approach, which targets perifollicular inflammation directly, aligns with this emerging research framework.

Because most of those products treat the surface of your scalp, not what's happening beneath it. Hair loss begins in the dermis — below the skin — where the follicle, its blood supply, and its surrounding tissue actually live. A scalp oil cannot penetrate to that level. Biotin supplements support hair structure but don't address inflammation, congestion, or circulatory failure at the root.

Prescription treatments like minoxidil work by dilating blood vessels — which can help in some cases — but they don't address the inflammatory environment that may be causing the loss in the first place. The moment you stop using them, hair loss typically resumes.

Dermotricology works differently. It targets the scalp ecosystem at a cellular level — clearing congestion, reducing inflammation, restoring microcirculation, and providing the nutritional environment dormant follicles need to reactivate. It doesn't mask the problem. It addresses the cause.

Potentially, yes. Heavy petroleum-based products — mineral oil, petrolatum, thick pomades — create a physical seal on the scalp that traps sebum, dead skin cells, and environmental debris in the follicle opening. Over time this congestion restricts the follicle's ability to breathe, receive nutrients, and produce healthy terminal hair.

This doesn't mean oils are categorically harmful — the right lightweight botanical oils used correctly can support scalp health. But the heavy grease-based products that have been culturally normalized for generations were formulated for cosmetic purposes, not scalp health, and they were not designed with melanin-rich skin biology in mind.

Genetics can predispose you to certain types of hair loss — but predisposition is not destiny. Many women with a genetic tendency toward androgenetic alopecia or diffuse thinning see significant improvement when the scalp environment is properly treated. Genetics determines the vulnerability; the scalp environment determines how that vulnerability expresses itself.

If you haven't had a clinical Dermotricology assessment, you may not have a complete picture of what's actually driving your hair loss — and what's addressable.

"It's not medical" is actually useful clinical information — it means the condition doesn't require prescription treatment, which opens the door to plant-based clinical intervention. This is precisely where Dermotricology fits in the care pathway. A dermatologist addresses medical skin disease. A Technician of Dermotricology addresses the scalp and skin ecosystem — the microbiome, barrier function, sebum balance, follicular health — using EU-regulated botanical protocols that produce clinical results without prescription requirements.

Kapyderm USA's positioning is deliberate: we are not competing with dermatology — we are filling the gap it leaves behind. When your dermatologist has ruled out medical conditions and you still have a scalp or skin issue affecting your quality of life, a certified Dermotricologist is the clinical next step.

The system is formulated to treat the underlying scalp environment that drives most forms of non-scarring hair loss — including diffuse thinning, early-to-mid stage traction alopecia, androgenetic alopecia, and stress or nutrition-related shedding. It is also used as a complementary protocol for early-stage CCCA under the guidance of a certified Dermotricologist.

Most clients experience a noticeable reduction in shedding within the first 2–4 weeks of Phase 1. Scalp irritation, burning, and itching typically calm within the first week as inflammation begins to clear.

Visible regrowth — new hair emerging from previously dormant follicles — generally begins between weeks 6 and 12, depending on the severity of the condition and how consistently the protocol is followed. Your Dermotricology specialist will track your progress and adjust your protocol at your second consultation.

Yes. The Kapyderm formulas are plant-based and free of harsh sulfates, steroids, and synthetic hormones. They are compatible with color-treated, relaxed, and chemically processed hair. Your Dermotricology specialist will review your current hair care routine during your first consultation and advise on any adjustments.

It depends on your protective style. The Base Tonic and Ampoule DT need direct scalp access for effective application. Your Dermotricology specialist will advise you on how to adapt the protocol to your current styling routine. In cases of active traction alopecia, reducing tension on the scalp during treatment significantly improves outcomes.

The Kapyderm system is 100% plant-based and contains no steroids, synthetic hormones, or harsh chemical agents. It has been clinically developed and refined over 35+ years by Laboratorios Kapyderm in Spain and is used by certified professionals worldwide.

Some clients experience mild initial scalp sensitivity during the first week as the detoxification process begins — this is normal and typically resolves quickly. Your specialist will guide you through what to expect at your first consultation.

In-person treatment at a certified Dermotricology center includes clinical scalp analysis equipment, professional-grade application techniques, and hands-on care from a trained specialist. For many conditions — particularly CCCA and advanced traction alopecia — in-person care produces faster and more comprehensive results.

The home treatment system uses the same clinical plant-based formulas and is designed for clients who don't have access to a certified center nearby, or who prefer to begin their restoration journey at home with expert guidance via Zoom. It is a legitimate clinical protocol — not a consumer product with professional branding.

Your consultations are conducted by a certified Master in Dermotricology — a practitioner who has completed advanced clinical training through Laboratorios Kapyderm's professional certification program. These are not general wellness coaches or brand representatives. They are clinically trained specialists in scalp biology and Dermotricology protocols.

First consultation — scheduled shortly after your purchase. Your specialist reviews your hair loss history, current scalp condition, lifestyle factors, and any products you're currently using. They walk you through your exact protocol step by step and answer every question you have before you begin.

Second consultation — scheduled 4–6 weeks into your treatment. Your specialist assesses your progress, reviews any changes in shedding or scalp condition, and adjusts your protocol for Phase 2 or continued active treatment as needed.

You will be contacted within 48–72 hours of your purchase to schedule your first consultation at a time that works for you.

The two included consultations cover your protocol setup and first progress review. If your condition requires additional follow-up, your specialist will discuss options with you at your second session. Additional consultations can be arranged directly with your practitioner.

The Hair Loss Home Treatment — including all six products and both expert Zoom consultations — is $225.97. Visit our store at kapydermusa.com/store for current pricing and available treatments.

All orders ship from within the United States. Standard delivery typically takes 5–7 business days. Expedited shipping options are available at checkout.

Because the treatment includes personalized expert consultations, we ask that you commit to the full Phase 1 protocol before evaluating results. If you have concerns about your treatment progress, please raise them with your Dermotricology specialist at your second consultation. Contact us directly at any time at contact@kapydermusa.com and we will work with you.

Yes. Kapyderm USA offers a professional partnership program for licensed salon owners, trichologists, and estheticians who want to offer Dermotricology services and retail products to their clients. Partners receive wholesale pricing, professional training resources, and ongoing support from Kapyderm USA.

Acne is driven by four simultaneous factors: excess sebum production (Driver 01), follicular hyperkeratinization — dead skin cells clogging the follicle (Driver 02), C. acnes bacterial dysbiosis (Driver 03), and systemic inflammation driven by gut dysbiosis, stress cortisol, and dietary factors (Driver 04).

Most OTC treatments address one driver. Benzoyl peroxide targets Driver 03. Salicylic acid targets Driver 02. Retinoids target Driver 02. Antibiotics target Driver 03. None address Driver 04 — systemic inflammation — because no topical can reach a systemic driver. This is why treatments work initially then plateau: the underlying internal environment continues recreating the conditions for acne regardless of what's applied topically.

50–75% of acne patients are now resistant to conventional antibiotic therapy. C. acnes resistance to macrolides has been documented as high as 60.1%. The mechanism: antibiotics eliminate sensitive C. acnes strains while resistant strains survive, proliferate, and establish dominance. Long-term use also disrupts the gut and skin microbiome — removing the beneficial bacteria that naturally regulate C. acnes populations — making acne worse over time while appearing to help short-term.

A December 2025 review in Molecules confirmed the chronic inflammatory acne cascade is driven by microbial dysbiosis, hyperkeratinisation, sebum overproduction, and inflammation — and that antibiotic resistance is a growing clinical challenge requiring alternative approaches. The Kapyderm Dermotricology system addresses all four drivers without antibiotics, without prescription requirements, and without resistance risk.

Hormonal acne is driven by androgen fluctuations, stress cortisol, and gut microbiome dysbiosis — not just surface bacteria. The classic pattern: breakouts concentrated along the lower face, jaw, and chin that worsen in the week before menstruation. Many women with hormonal acne have completely normal hormone levels on blood tests, because the driver isn't circulating hormones — it's how their skin cells process those hormones locally, and how gut dysbiosis amplifies the inflammatory response.

Standard topical treatments fail because they can't reach the internal hormonal environment. The Kapyderm protocol addresses hormonal acne through the Seborregulator Tonic (sebum regulation) topically and dePure (botanical liver and systemic detox support) internally — the inside-out approach that reaches what topicals cannot.

Cystic acne is the most severe form — inflammation spreads deep into the dermis, creating large painful cysts that cause permanent scarring without clinical intervention. It requires more than home treatment: the Kapyderm certified network offers a 5-month progressive in-center protocol validated with real before/after clinical documentation.

The protocol progresses across 5 months: Months 1–2 control infection and inflammation using Organic Turba, Ampoule N, Fungi-Activ, Seborregulator, Kapydermia Professional Plus, LLLT Laser, and therapeutic mask. Month 3 adds Cold & Hot Plasma immediately post-Turba for amplified anti-inflammatory effect. Month 4 applies Fungi-Activ and Seborregulator post-plasma for deeper penetration. Month 5 introduces Ampoule de Placenta and the Kapystetik regeneration line for scar prevention. No antibiotics. No prescription. No isotretinoin.

Fungal acne (Pityrosporum folliculitis) is caused by Malassezia yeast overgrowth — not C. acnes bacteria. It presents as uniform, small, itchy bumps typically on the forehead, chest, or upper back. The critical distinction: fungal acne does not respond to antibiotics and may worsen with them, since antibiotics disrupt the bacterial balance that naturally keeps yeast in check.

Fungi-Activ in the Kapyderm system has documented antifungal botanical activity directly applicable to this presentation. This is one of the most frequently misdiagnosed skin conditions — if you've been through multiple rounds of antibiotics with no improvement, fungal acne should be considered.

A May 2026 review in Applied Sciences confirmed that gut dysbiosis influences acne through IGF-1 and mTORC1 — the same metabolic regulators that directly drive sebum overproduction. Gut barrier disruption allows inflammatory compounds into systemic circulation, amplifying sebum production, worsening the skin microbiome, and sustaining the acne cycle between breakouts.

This is the evidence-based rationale for dePure as an internal component of the Kapyderm acne protocol. No topical product can reach a systemic inflammatory driver — which is why treating acne only topically produces temporary results regardless of how effective the topical is.

Yes — particularly cystic and nodular acne. When inflammation destroys collagen and elastin in the dermis, atrophic (pitted) scars form. Post-inflammatory hyperpigmentation (PIH) — flat dark marks after a lesion heals — is not a true scar but can persist for months, especially on darker skin tones where melanin overproduction in response to inflammation is more pronounced.

The most effective intervention is preventing the inflammation that causes scarring in the first place — which is the clinical rationale for the Kapyderm 5-month in-center protocol's Month 5 regeneration phase (Ampoule de Placenta + Kapystetik line). For darker skin tones specifically, a plant-based botanical system that clears acne without the irritation risk of synthetic acids is particularly valuable — because irritation from treatment itself can worsen PIH.

Yes — the protocol is specifically formulated for multi-zone application. The Normalizing Base Cleanser, Fungi-Activ, and Seborregulator Tonic are all designed for body use. The internal components (dePure, Revital) work systemically regardless of where acne presents. Fungi-Activ is applied directly to active lesions wherever they occur — face, chest, back, or shoulders.

Because moisturizing addresses the symptom — not the cause. Chronic dry skin (xerosis) is a barrier integrity failure: the lipid matrix between skin cells has been depleted, allowing transepidermal water loss (TEWL) at a rate the skin cannot compensate for regardless of how much moisturizer is applied on top. Common moisturizers add moisture from the outside; they don't repair the structural lipid deficit that prevents the skin from retaining moisture on its own.

The Kapyderm dry skin protocol addresses three simultaneous root causes: the structural ceramide and lipid deficit in the barrier, the skin microbiome disruption that prevents self-repair, and the nutritional deficiencies that reduce the skin's capacity to synthesize barrier lipids internally. The protocol includes topical botanical lipid repair, microbiome-compatible cleansing, and internal botanical support — because true barrier restoration requires inside-out intervention.

CeraVe and La Roche-Posay are surface-level barrier treatments. They add ceramides and lipids from the outside — which provides temporary relief — but doesn't address why the barrier is depleted in the first place. They are also formulated with synthetic preservatives, emulsifiers, and fragrance compounds that can perpetuate microbiome disruption in sensitive skin types.

The Kapyderm system uses 100% plant-based botanical formulas that restore barrier function while simultaneously supporting the skin microbiome — not just adding lipids on top of disrupted skin. The internal botanical supplement component also addresses nutritional deficiencies that conventional skincare products can never reach. This is the difference between symptomatic management and genuine barrier restoration.

Up to 70% of women report sensitive skin — yet most products marketed for "sensitive skin" simply remove the most obvious irritants without addressing the underlying biology. True sensitive skin is a neurogenic inflammation pattern: the skin's sensory nerve fibers are hyper-reactive, triggering redness, stinging, burning, or flushing in response to stimuli that wouldn't affect non-sensitive skin.

The root causes are barrier dysfunction (allowing environmental triggers through the skin) and skin microbiome dysbiosis (reducing the beneficial bacteria that normally buffer inflammatory responses). The Kapyderm sensitive skin protocol targets both — botanical barrier repair and microbiome-compatible formulas that calm the neuro-dermal inflammation response without the synthetic actives that typically trigger sensitive skin reactions.

Yes — and it is particularly well-suited for melanin-rich skin precisely because it does not use the synthetic acids, high-concentration retinoids, or aggressive exfoliants that carry the highest risk of post-inflammatory hyperpigmentation (PIH) on darker skin tones. PIH — dark marks triggered by inflammation or irritation — is disproportionately severe and persistent on Black, Brown, and Hispanic skin.

A plant-based botanical system that clears skin conditions without irritation risk is clinically rational for skin of color. The Kapyderm system's EU-regulated formulas were designed for biocompatibility across all skin types — including the most reactive and melanin-rich skin.

Yes — and this is one of the most important things to understand about Dermotricology. The discipline treats the scalp and skin as a unified clinical system. Kapyderm USA offers complete treatment protocols for a wide range of skin conditions, not just hair loss.

Skin is now half of Kapyderm USA's clinical focus. The same 35+ years of EU-regulated research that drives the hair loss protocols also drives the skin treatment formulas — because the cellular mechanisms are often shared. Barrier dysfunction, microbiome disruption, sebum imbalance, and chronic inflammation drive both scalp conditions and skin conditions. The Kapyderm system addresses both.

Kapyderm USA offers complete clinical home treatment protocols for the following skin conditions:

• Dry skin — ceramide barrier repair and microbiome rebalancing
• Acne — anti-inflammatory, seboregulating, and microbiome-correcting protocols
• Eczema & atopic dermatitis — soothing, barrier-repair, and anti-inflammatory protocols
• Psoriasis — keratolytic, anti-inflammatory, and barrier restoration for body psoriasis
• Sensitive skin — neuro-dermal soothing and microbiome-compatible protocols
• Patchy skin & hyperpigmentation — botanical brightening and tone correction
• Dark circles — periorbital microvascular and pigmentation protocols
• Anti-aging — collagen support, dermal restructuring, and antioxidant protection
• Micro-lifting — botanical skin-tightening and elastin support
• Cellulite & stretch marks — microcirculation, connective tissue, and dermal repair protocols

CeraVe and La Roche-Posay are surface-level barrier treatments. They add ceramides and lipids to the skin from the outside — which helps temporarily, but doesn't address why the barrier is depleted in the first place.

The Kapyderm dry skin protocol addresses three root causes simultaneously: the structural lipid deficit in the barrier, the skin microbiome disruption that prevents barrier repair, and the nutritional deficiencies that reduce the skin's capacity to synthesize ceramides internally. The protocol includes a topical lipid repair system, a microbiome-compatible cleanser, and an internal botanical supplement — because true barrier restoration requires inside-out intervention, not just topical application.

Yes — and this is common. Many Kapyderm clients have overlapping conditions. Someone with seborrheic dermatitis on the scalp often has dry, sensitive, or reactive skin elsewhere. Someone with androgenetic alopecia may also be dealing with chronic dry skin or mild eczema.

A certified Technician of Dermotricology can map your complete condition profile — scalp and skin — and design a protocol that addresses both. The Kapyderm product system is designed for this: the cleansing bases, tonics, ampoules, and nutritional supplements work across conditions, not just within a single treatment silo.

Seborrheic dermatitis is a chronic inflammatory scalp and skin condition driven by Malassezia yeast overgrowth on sebum-rich skin surfaces. It presents as flaking, redness, and scaling on the scalp, face (particularly around the nose and eyebrows), chest, and back. Unlike dandruff — which is superficial — seborrheic dermatitis involves active inflammation of the skin's upper layers and is considered a chronic condition that requires ongoing management rather than one-time treatment.

Yes — the Kapyderm Dermotricology protocol addresses seborrheic dermatitis through Fungi-Activ (antifungal botanical complex targeting Malassezia), the appropriate cleansing base for the scalp type, and Seborregulator Tonic for sebum regulation. The protocol targets both the inflammatory response and the sebum-rich environment that allows yeast to proliferate. Read the full clinical guide at kapydermusa.com/blog/seborrheic-dermatitis-scalp-treatment.

A Certified Technician of Dermotricology is a licensed professional — salon owner, trichologist, esthetician, or MedSpa clinician — who has completed the full Kapyderm clinical training and certification program through Fundesmo, the exclusive U.S. source of Dermotricology education.

Certification covers scalp and skin diagnosis using the Kapykon digital evaluation system, the full Kapyderm product and protocol library, clinical treatment procedures, and client consultation methodology. Every certified professional in the Kapyderm USA network has completed this training and passed the certification assessment.

This is not a marketing certification. It is a clinical designation — the only one of its kind in the United States.

The Kapykon is a digital scalp imaging system used by certified Kapyderm treatment centers to evaluate the scalp at a clinical level before any treatment begins. It allows the practitioner to assess follicular health, sebum distribution, scalp type (K1 or K2), inflammation markers, and the condition of the scalp microbiome — all before prescribing a protocol.

This diagnostic step is what separates the Kapyderm system from every retail hair care brand. Products purchased at Sephora or Amazon are selected by the consumer based on symptom descriptions. Kapyderm protocols are prescribed by a certified clinician based on a diagnostic evaluation. The distinction is clinical — not cosmetic.

As of 2026, the Kapyderm USA certified center network includes 29+ certified professionals across 13+ states: Florida, North Carolina, Georgia, Texas, Ohio, Pennsylvania, New York, Maryland, Tennessee, South Carolina, Virginia, Washington, and Arizona — with the network growing.

Every center uses the Kapykon digital evaluation system and delivers protocols built on the same EU-regulated clinical research. There is no variation in clinical standard across the network.

By design. Kapyderm is a clinical system, not a retail product line. The protocols require diagnosis before prescription — which is only possible through a certified professional or a direct consultation with a Kapyderm specialist.

Selling through Amazon or Sephora would mean selling individual products without the clinical context that makes them work. A client who buys the Ampoule DT without a proper scalp evaluation, the correct cleansing base for their scalp type, and the appropriate nutritional support is unlikely to get the results the system is designed to deliver. The channel restriction is a clinical decision — not a distribution limitation.

There are two paths to joining the Kapyderm USA professional network:

• Authorized Retailer — free signup, 50% wholesale pricing, listing in the Find a Center directory, and access to the full Kapyderm product line and training resources. No minimums. No contract.
• Treatment Center Launch Program — full clinical setup including the Kapykon digital evaluation equipment, a 3-day Zoom certification masterclass, starter product inventory, and dedicated support from Kapyderm USA. This is the path to becoming a fully operational certified treatment center.

Nutrafol is a supplement — a single oral intervention targeting systemic nutritional factors in hair loss. It is a legitimate product with documented efficacy in some populations, particularly for stress-induced and nutritional-deficiency shedding. But it has real limitations:

• It doesn't address the scalp microenvironment, sebum accumulation, or scalp type
• Its clinical trials are company-sponsored and small-scale
• It was acquired by Unilever in 2022 — a mass-market consumer goods company
• It has no in-center clinical component — no diagnosis, no scalp evaluation, no practitioner involved

The Kapyderm system includes an internal botanical supplement and a complete topical protocol and clinical diagnosis by a certified professional. It addresses hair loss at the follicular, microbiome, sebum, and nutritional level simultaneously. These are not comparable products — they operate in different clinical categories.

Nioxin is a scalp-cleansing and volumizing system owned by Wella (now Coty). It is designed to create the appearance of fuller hair and reduce scalp buildup — which it does reasonably well. It is not a clinical treatment for hair loss.

Nioxin does not address DHT-driven follicular miniaturization, scalp microbiome disruption, the SQOOH oxidation cascade, or the inflammatory mechanisms behind androgenetic alopecia. It is a professional shampoo system with a clinical-sounding name. Kapyderm is a clinical intervention system with peer-reviewed research behind its mechanisms. They are not in the same category.

No — and this distinction matters. Minoxidil is a vasodilator originally developed as a blood pressure medication. It stimulates hair growth by increasing blood flow to the follicle and extending the anagen (growth) phase. It works for many people — but it has significant limitations:

• Results stop if you stop using it — hair loss returns
• It doesn't address the root cause of follicular miniaturization
• Side effects include scalp irritation, initial shedding, and in some cases systemic cardiovascular effects
• It is not effective for all hair loss types

Kapyderm contains no minoxidil. The system addresses hair loss by correcting the scalp microenvironment — the perifollicular sebum accumulation, oxidative stress, microbiome disruption, and nutritional deficits that drive follicular miniaturization — rather than mechanically forcing a growth response. The goal is to restore the conditions under which the follicle can function correctly, not to override the system with a pharmaceutical stimulus.

Three reasons:

• EU-regulated clinical formulas — every Kapyderm product is developed under EU Cosmetics Regulation (EC) No 1223/2009, one of the strictest regulatory frameworks in the world. The ingredient standards, safety testing, and efficacy validation required under EU regulation are significantly more demanding than U.S. FDA cosmetic standards.
• Complete clinical system — you are not buying a single product. You are buying a complete multi-component protocol — cleanser, tonic, ampoule, internal supplement — designed to work as an integrated system. Buying each component separately from a retail brand would cost more and deliver less.
• Clinical support included — every home treatment includes expert consultation with a certified Technician of Dermotricology. The clinical oversight is built into the price. This is not available from any retail brand at any price point.

The honest comparison is not Kapyderm vs. a drugstore shampoo. It is Kapyderm vs. dermatology visits, PRP treatments, or surgical hair restoration — all of which cost significantly more and carry more risk.